Phase II study of biweekly cetuximab plus irinotecan for unresectable colorectal cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Biweekly cetuximab plus irinotecan Primary outcome(s): response rate Study Design: Single arm Non-randomized
创建时间：
2009-04-15
